GlobeNewswire Inc | Nov 10, 2021 04:01PM EST

November 10, 2021

GAITHERSBURG, Md., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Companys management team will be presenting virtually at the following investor conferences in November 2021:

-- Stifels 2021 Virtual Healthcare ConferenceMonday, November 15, 202110:40 am Eastern Time

-- Jefferies London Healthcare ConferenceThursday, November 18, 20218:00 am GMT

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis B (HepTcell). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedInFollow @AltimmuneInc on Twitter

Altimmune Investor & Media Contact:

Will BrownChief Financial OfficerPhone: 240-654-1450wbrown@altimmune.com